Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite

被引:59
|
作者
Flesch, M
Kilter, H
Cremers, B
Laufs, U
Südkamp, M
Ortmann, M
Müller, FU
Böhm, M
机构
[1] Univ Cologne, Innere Med Klin 3, D-50924 Cologne, Germany
[2] Univ Cologne, Klin Herz & Thoraxchirurg, D-50924 Cologne, Germany
[3] Univ Cologne, Inst Pathol, D-50924 Cologne, Germany
[4] Univ Munster, Inst Pharmakol & Toxikol, D-4400 Munster, Germany
关键词
D O I
10.1016/S0735-1097(98)00660-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study examined the effects of endotoxin on cardiac contractility in human myocardium. BACKGROUND In animal myocardium, endotoxin and cytokine treatment led to enhanced inducible nitric oxide synthase (iNOS) expression and contractile dysfunction. Effects in human myocardium are unknown. METHODS Left ventricular myocardial preparations from failing (n = 18) and nonfailing (n = 5) human hearts were incubated for 6 and 12 h in tyrode solution or in tyrode plus lipopolysaccharides (LPS), with LPS plus N-G-mono-methyl-L-arginine (L-NMMA), with LPS plus hemoglobin or with LPS plus the superoxide scavenger 4,5-dihydroxy-1,3-benzene disulfonic acid (Tiron). Force of contraction in response to isoprenaline (0.001 to 3 mu mol/liter) was determined in electrically stimulated muscle preparations. The iNOS mRNA expression was examined by in situ hybridization and by polymerase chain reaction. The cyclic guanosine monophosphate (cGMP) levels were determined by radioimmunoassay. RESULTS Isoprenaline concentration dependently increased force of contraction. Six and 12 hours of LPS treatment of failing myocardium decreased maximum inotropic response to isoprenaline by 54% (p = 0.009) and by 69% (p = 0.0023), respectively. In nonfailing myocardium, 12 h of LPS treatment decreased maximum inotropic effect of isoprenaline by 66% (p < 0.001). The LPS effects were attenuated by L-NMMA, hemoglobin and also Tiron. The iNOS mRNA was expressed in all LPS-treated preparations but also in most control myocardial preparations. In situ hybridization revealed iNOS expression within cardiac myocytes. There nas no increase in myocardial cGMP content in response to endotoxin. CONCLUSIONS Endotoxin exposure of human myocardium leads to a depression of cardiac contractility, which is mediated by enhanced iNOS activity and release of nitric oxide (NO). Consecutive reaction of NO with superoxide and formation of peroxynitrite may contribute to the decrease in force of contraction. (J Am Coll Cardiol 1999;33:1062-70) (C) 1999 by the American College of Cardiology.
引用
收藏
页码:1062 / 1070
页数:9
相关论文
共 50 条
  • [41] Nitric oxide and peroxynitrite in the perinatal period
    Beckman, JS
    Viera, L
    Estévez, AG
    Teng, RJ
    [J]. SEMINARS IN PERINATOLOGY, 2000, 24 (01) : 37 - 41
  • [42] Reactivity of peroxynitrite and nitric oxide with LDL
    Botti, H
    Trostchansky, A
    Batthyány, C
    Rubbo, H
    [J]. IUBMB LIFE, 2005, 57 (06) : 407 - 412
  • [43] Nitric oxide and peroxynitrite in health and disease
    Pacher, Pal
    Beckman, Joseph S.
    Liaudet, Lucas
    [J]. PHYSIOLOGICAL REVIEWS, 2007, 87 (01) : 315 - 424
  • [44] Mapping DNA lesion caused by nitric oxide and peroxynitrite in human genes
    Cloutier, JF
    Dong, M
    O'Connor, T
    Dedon, PC
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (12) : 1677 - 1677
  • [45] Nitrosation of melatonin by nitric oxide and peroxynitrite
    Blanchard, B
    Pompon, D
    Ducrocq, C
    [J]. JOURNAL OF PINEAL RESEARCH, 2000, 29 (03) : 184 - 192
  • [46] Nitric oxide and peroxynitrite interactions with mitochondria
    Radi, R
    Cassina, A
    Hodara, R
    [J]. BIOLOGICAL CHEMISTRY, 2002, 383 (3-4) : 401 - 409
  • [47] Nitric oxide and peroxynitrite in lipid peroxidation
    Rubbo, H
    [J]. MEDICINA-BUENOS AIRES, 1998, 58 (04) : 361 - 366
  • [48] Peroxynitrite inhibition of nitric oxide synthases
    Pasquet, JPEE
    Zou, MH
    Ullrich, V
    [J]. BIOCHIMIE, 1996, 78 (8-9) : 785 - 791
  • [49] The biological chemistry of nitric oxide and peroxynitrite
    Pfeiffer, S
    Mayer, B
    [J]. NITRIC OXI DE: BASIC RESEARCH AND CLINICAL APPLICATIONS, 2001, 317 : 35 - 43
  • [50] Nitric oxide and peroxynitrite in airway disease
    Nijkamp, FP
    Folkerts, G
    [J]. PHARMACOLOGY AND THERAPEUTICS IN THE NEW MILLENNIUM, 2001, : 599 - 619